article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

RMMs aim to optimise the safe and effective use of medical products in clinical practice by improving their risk-benefit balance. As does the US Food and Drug Administration (FDA): REMS Assessment: Planning and Reporting Guidance for Industry Draft Guidance. About the author. References. Risk management plan [Internet].

article thumbnail

Antidepressants and Suicide: Why Don’t People Think There’s a Link?

The People's Pharmacy

At one point, she was on multiple medications, some contraindicated. When she died, she had just been put on an antidepressant with a black-box FDA suicide warning. The drug was eventually outlawed, but only after thousands of adverse reactions and over a hundred deaths worldwide. Tragically, she ended her own life.

FDA 81
article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

After this incident CAR-related toxicity scales and guidelines were established to prevent adverse reactions. Prof Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, specialising in Internal Medicine and Hematology at the Rambam Medical Center, Haifa, and in Hematopoiesis at TA University.